Profile | GDS2987 / GI_7706492-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 3.4 | 13 |
GSM215244 | HMVEC_vehicle_rep2 | 15.8 | 38 |
GSM215253 | HMVEC_vehicle_rep3 | 20.9 | 54 |
GSM215254 | HMVEC_atorvastatin_rep1 | 21.5 | 49 |
GSM215282 | HMVEC_atorvastatin_rep3 | 18.8 | 40 |
GSM215344 | HMVEC_atorvastatin_rep2 | 18.8 | 43 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 13.8 | 27 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | 24.8 | 45 |
GSM215296 | HMVEC_SLx2119_rep3 | 59.5 | 66 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 53.7 | 62 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 21.8 | 36 |
GSM215312 | PASMC_atorvastatin_rep2 | 10.1 | 17 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 20.6 | 33 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 4.3 | 8 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 3.7 | 7 |
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 55.9 | 68 |
GSM215331 | Fibroblasts_vehicle_rep2 | 17.1 | 43 |
GSM215332 | Fibroblasts_vehicle_rep3 | 30.4 | 62 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 21.5 | 49 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 18.9 | 46 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 37.9 | 62 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | ||
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | ||
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 13.5 | 36 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 6.4 | 19 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 17.6 | 44 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 9.7 | 25 |